Zacks: Analysts Expect Nu Skin Enterprises, Inc. (NYSE:NUS) Will Announce Earnings of $0.82 Per Share

Equities analysts forecast that Nu Skin Enterprises, Inc. (NYSE:NUS – Get Rating) will announce earnings per share of $0.82 for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Nu Skin Enterprises’ earnings. The highest EPS estimate is $0.85 and the lowest is $0.78. Nu Skin Enterprises posted earnings of $1.15 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 28.7%. The business is expected to announce its next quarterly earnings report on Monday, January 1st.

On average, analysts expect that Nu Skin Enterprises will report full year earnings of $3.80 per share for the current fiscal year, with EPS estimates ranging from $3.73 to $3.85. For the next fiscal year, analysts forecast that the firm will post earnings of $4.09 per share, with EPS estimates ranging from $4.05 to $4.12. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research firms that that provide coverage for Nu Skin Enterprises.

Nu Skin Enterprises (NYSE:NUS – Get Rating) last announced its earnings results on Wednesday, May 4th. The company reported $0.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.73 by $0.03. Nu Skin Enterprises had a net margin of 5.28% and a return on equity of 22.05%. The business had revenue of $604.90 million for the quarter, compared to analyst estimates of $579.70 million. During the same quarter in the previous year, the firm posted $0.91 earnings per share. Nu Skin Enterprises’s revenue was down 10.7% compared to the same quarter last year.

A number of equities analysts recently issued reports on NUS shares. Jefferies Financial Group boosted their target price on shares of Nu Skin Enterprises from $61.00 to $75.00 in a research report on Thursday, February 17th. Zacks Investment Research raised shares of Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $57.00 price target on the stock in a report on Tuesday, March 29th. TheStreet lowered shares of Nu Skin Enterprises from a “b” rating to a “c+” rating in a report on Friday, February 18th. DA Davidson boosted their price target on shares of Nu Skin Enterprises from $47.00 to $50.00 and gave the company a “neutral” rating in a report on Thursday, February 17th. Finally, StockNews.com lowered shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Friday, May 13th. Three analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $60.60.

In other news, Director Andrew D. Lipman sold 1,000 shares of the company’s stock in a transaction dated Friday, April 22nd. The shares were sold at an average price of $47.72, for a total value of $47,720.00. Following the sale, the director now owns 71,214 shares of the company’s stock, valued at approximately $3,398,332.08. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Ryan S. Napierski sold 25,000 shares of the company’s stock in a transaction dated Friday, February 25th. The stock was sold at an average price of $47.40, for a total transaction of $1,185,000.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 28,000 shares of company stock worth $1,333,390. 2.80% of the stock is owned by insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of NUS. State Street Corp lifted its position in Nu Skin Enterprises by 317.6% during the 1st quarter. State Street Corp now owns 6,520,579 shares of the company’s stock valued at $312,205,000 after purchasing an additional 4,959,089 shares during the period. Millennium Management LLC lifted its position in Nu Skin Enterprises by 1,050.2% during the 4th quarter. Millennium Management LLC now owns 703,938 shares of the company’s stock valued at $35,725,000 after purchasing an additional 642,738 shares during the period. Norges Bank acquired a new position in Nu Skin Enterprises during the 4th quarter valued at about $23,843,000. Cooper Creek Partners Management LLC acquired a new position in Nu Skin Enterprises during the 4th quarter valued at about $23,609,000. Finally, The Manufacturers Life Insurance Company lifted its position in Nu Skin Enterprises by 423.3% during the 4th quarter. The Manufacturers Life Insurance Company now owns 430,185 shares of the company’s stock valued at $21,832,000 after purchasing an additional 347,985 shares during the period. Institutional investors and hedge funds own 93.79% of the company’s stock.

NUS stock traded down $1.72 on Friday, reaching $45.42. 5,157 shares of the company were exchanged, compared to its average volume of 989,149. Nu Skin Enterprises has a 12 month low of $39.40 and a 12 month high of $62.70. The stock’s fifty day moving average price is $46.68 and its 200 day moving average price is $47.92. The firm has a market capitalization of $2.28 billion, a PE ratio of 17.46 and a beta of 1.24. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.72 and a quick ratio of 0.95.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 8th. Stockholders of record on Friday, May 27th will be issued a $0.385 dividend. This represents a $1.54 annualized dividend and a dividend yield of 3.39%. The ex-dividend date is Thursday, May 26th. Nu Skin Enterprises’s payout ratio is 57.04%.

About Nu Skin Enterprises (Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

Featured Stories